Volume 27, Issue 149 (6-2017)                   J Mazandaran Univ Med Sci 2017, 27(149): 225-238 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Soleimani N. The Role of Helicobacter Pylori in Gastric Cancer and its Clinical Applications in Cancer Treatment . J Mazandaran Univ Med Sci 2017; 27 (149) :225-238
URL: http://jmums.mazums.ac.ir/article-1-7625-en.html
Abstract:   (29041 Views)

The repeated exposure of a normal cell to carcinogenic agents may lead to its mutation, which changes into a cancer cell. In this case, the structure and function of the cells would alter, and they do not act normally. Chemicals, sun exposure, shortwaves, viruses, and bacteria play a significant role in cancer. Among the infectious and bacterial agents causing cancer, Helicobacter pylori (H. pylori) is the most important bacterium involved in carcinogenesis. H. pylori causes chronic gastritis, peptic ulceration, and gastric cancer. Recently, this bacterium has been classified as class I carcinogen (i.e., a definite cause of cancer in humans). Despite the pathogenic effect of this bacterium, it has been recently affirmed to induce apoptosis in cancer cell line and affect the reduction of tumor size in animal models. This result suggests that some factors of H. pylori can be used as a new tool in future therapeutic strategies implemented in cancer immunotherapy.

Full-Text [PDF 411 kb]   (6074 Downloads)    
Type of Study: Review | Subject: infection

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb